EGFR and neoplasm: In pancreatic tumors, the epidermal growth factor receptor type 1 (EGFR) is often overexpressed, meaning these signaling pathways are excessively activated, leading to the excessive growth and spread of tumor cells (Fjällskog et al., 2003; Tobita et al., 2003).